Healthcare Investors and Lenders
Clear All
Results
Showing of
New York State Department of Health Issues Long-Awaited Guidance on Material Transactions Law
Healthcare Transactions in Illinois: What Investors Should Know
Preparing for a Civil Investigative Demand as a Healthcare Investor in Massachusetts
New Year, Same Bill: California Reintroduces Bill Aimed at Healthcare Private Equity Investment
Preparing for DSO Consolidation Restrictions and Oversight with Legal Counsel
A Year-End Report for Healthcare Antitrust and What to Expect Later in 2025
Podcast - Rewriting the Narrative of Private Equity in Healthcare
What's Next for Private Equity and Healthcare Investment
Antitrust Reporting Requirements for Healthcare M&A – Case Study Analysis of Federal and State Developments
Intercreditor Agreements in Skilled Nursing Facilities: Collateral Allocations That May Surprise You!
When is the Market ‘Right’ for a Sale?
5 Key Takeaways from Panel Discussion with the California Office of Health Care Affordability
Significant Changes to SNF Disclosure Requirements Prompt Need for Regulatory Review
Drafting for Success and Protecting Yourself Against Failure
5 Key Antitrust Takeaways from Holland & Knight's Panel at Nashville Healthcare Sessions 2024
Podcast - What’s Next After Gov. Gavin Newsom’s Veto in California?
California Governor Vetoes Assembly Bill 3129: What's Next?
California Ends the Legislative Session with Expanded Reporting Requirements, Less Clarity
Healthcare Private Equity Transactions Under Scrutiny: Midyear Review
Friendly PC Model Survives in California After Envision Healthcare Litigation Settlement
Page 1 of 3
